PhotoCure starts Phase III Hexvix trial

PhotoCure (OSE:PHO) began enrollment in a European Phase III trial of its Hexvix fluorescence cystoscopy to detect bladder cancer. The company plans to enroll 300 patients in the trial, and said it wi...